Test Price
800 AED✅ Home Collection Available
Menopausal Screening Panel in UAE | 800 AED | 2026 DHA Guidelines
تحليل فحص انقطاع الطمث في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
يقدم هذا التحليل الشامل لفحص انقطاع الطمث تقييماً هرمونياً دقيقاً وفقاً لمعايير هيئة الصحة بدبي لعام 2026، مع ضمان دقة تشخيصية تصل إلى 99.9% عبر مختبر معتمد دولياً بشهادة ISO 9001:2015، ويشمل خدمة سحب عينات منزلية متميزة مع استشارة طبية هاتفية بعد صدور النتائج.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via CLIA/EIA validated against LC-MS/MS reference methodology, processed in our ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy — available 8 AM to 11 PM daily across all Emirates.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed physicians to support result interpretation and next-step planning.
- ✓ Insurance Support: Direct Billing Verification via WhatsApp at +971 54 548 8731 — instant confirmation for 40+ UAE insurer networks.
Clinical Overview
The Menopausal Screening Panel is a comprehensive hormonal evaluation designed to assess ovarian function and menopausal status through quantitative measurement of key reproductive hormones — including Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Estradiol (E2), and Progesterone — using Chemiluminescent Immunoassay (CLIA) and Enzyme Immunoassay (EIA) technologies. This panel serves as an essential diagnostic tool for perimenopausal transition assessment, premature ovarian insufficiency screening, and treatment monitoring for women experiencing vasomotor symptoms, menstrual irregularities, or fertility concerns in the UAE.
لوحة فحص انقطاع الطمث هي تقييم هرموني شامل مصمم لتقييم وظيفة المبيض وحالة انقطاع الطمث من خلال القياس الكمي للهرمونات التناسلية الرئيسية باستخدام تقنيات المقايسة المناعية الكيميائية والإنزيمية المتطورة.
| Feature | Our Test — Menopausal Screening Panel | Closest Alternative — Standard Hormone Panel |
|---|---|---|
| Methodology | CLIA + EIA (dual-platform, cross-validated vs. LC-MS/MS reference) | Single-platform immunoassay only; limited cross-validation |
| Analytical Sensitivity | ≥99.9% — ISO 9001:2015 validated | Typically 95–97%; variable QC protocols |
| Turnaround Time | Same Day (sample by 9 AM) | 2–5 working days |
| Home Collection | Included — ISO Cold-Chain, 8 AM–11 PM | Often unavailable or surcharged |
| Post-Test Consultation | Included — DHA-licensed physician tele-guidance | Rarely included; requires separate GP visit |
| Price | 800 AED (All-Inclusive) | 600–1,200 AED (variable; excludes consult) |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY, MBBS, MD — DHA License: 61713011
Consultant Gynecologist & Reproductive Endocrinologist
"Menopause is a clinical diagnosis supported — not defined — by laboratory values. The Menopausal Screening Panel provides objective hormonal data that must be interpreted in the context of your unique symptom profile, age, menstrual history, and overall health status. A single elevated FSH does not confirm menopause; rather, serial trends correlated with clinical findings guide accurate diagnosis and personalized management."
"I urge every patient to view this panel as a conversation starter with their gynecologist — not a standalone verdict. Your body's transition is nuanced, and our telephonic guidance ensures you never navigate these results alone."
"With three decades of clinical experience serving women across the UAE, I can confidently state that early, accurate hormonal assessment empowers better health outcomes — from bone preservation strategies to cardiovascular risk mitigation during the menopausal transition."
Clinical Medication Notice:
Do not discontinue any prescribed medication — including Hormone Replacement Therapy (HRT), oral contraceptives, or any endocrine-modulating drug — without consulting your treating physician prior to or following this test. Abrupt cessation of hormonal therapy may precipitate significant adverse physiological effects and confound diagnostic interpretation.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do NOT proceed without physician clearance):
- Confirmed or suspected pregnancy — must be ruled out via serum β-hCG prior to menopausal panel interpretation
- Active use of combined hormonal contraceptives without documented physician awareness
- Current Hormone Replacement Therapy (HRT) without a minimum 6-week washout period (unless monitoring on-therapy levels per specialist directive)
- Recent (within 8 weeks) unilateral or bilateral oophorectomy
- Active chemotherapy or pelvic radiation therapy — gonadal suppression confounds results
ER Red Flags — Seek Immediate Medical Attention:
- Heavy, uncontrolled vaginal bleeding with clots larger than 2 cm or soaking through pads hourly
- Acute, severe pelvic or lower abdominal pain of sudden onset
- Signs of rapid-onset hyperandrogenism: sudden voice deepening, hirsutism, or clitoromegaly
- Postmenopausal bleeding (any vaginal bleeding occurring ≥12 months after last menstrual period)
- Syncope, dizziness, or hemodynamic instability with pelvic symptoms
Pre-Test Information & Specimen Logistics
Specimen Requirements:
5 mL (3 mL minimum) serum collected in 1 SST (Serum Separator Tube). No fasting or special preparation is required. However, patients must disclose all current medications, supplements, and hormonal therapies to the phlebotomist and ordering physician, as exogenous hormones, biotin supplements (≥5 mg/day), and certain herbal preparations may interfere with immunoassay accuracy.
Transport & Stability:
Specimen must be shipped refrigerated (2–8°C) or frozen (-20°C) via ISO-certified cold-chain logistics. Our home collection team ensures pre-analytical stability from venipuncture to laboratory receipt within 4 hours across all Emirates. Samples drawn by 9 AM are processed and reported the same day.
Methodology Note:
CLIA (Chemiluminescent Immunoassay) and EIA/ELISA (Enzyme Immunoassay) are employed as the primary analytical platforms. Both methods are validated and cross-calibrated against the 2026 gold-standard LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry) reference method to ensure accuracy across the perimenopausal hormonal range where low-concentration estradiol quantification is clinically critical.
Patient FAQ & Clinical Guidance
Q1: What does the Menopausal Screening Panel measure, and how is it interpreted?
The Menopausal Screening Panel quantitatively measures serum FSH, LH, Estradiol (E2), and Progesterone levels to assess ovarian reserve and function, providing objective biochemical data that must be interpreted alongside clinical symptoms, age, and menstrual history by a DHA-licensed gynecologist. Elevated FSH levels (typically ≥25–30 IU/L) in conjunction with low Estradiol suggest diminished ovarian function consistent with perimenopause or menopause, but a single measurement is not diagnostic. Our telephonic post-test guidance ensures you receive context-specific interpretation aligned with 2026 DHA clinical pathways.
يقيس تحليل فحص انقطاع الطمث مستويات هرمون FSH وLH والإستراديول والبروجسترون في المصل لتقييم وظيفة المبيض، ويجب تفسير النتائج مع الأعراض السريرية والعمر والتاريخ الطبي من قبل طبيب أمراض النساء المرخص من هيئة الصحة بدبي.
Q2: Is fasting required before the Menopausal Screening Panel, and can medications affect results?
No fasting is required for this blood test; however, certain medications — including hormonal contraceptives, HRT, biotin supplements exceeding 5 mg daily, and some herbal preparations — can significantly alter hormone measurements and must be disclosed to your ordering physician prior to sample collection. We recommend scheduling your draw in the morning (8–11 AM) when FSH and Estradiol levels are most stable for clinical interpretation. If you are on HRT, your physician may advise a monitored washout period or interpret results in the context of ongoing therapy — never self-discontinue prescribed hormones.
لا يلزم الصيام قبل إجراء هذا التحليل، ولكن بعض الأدوية مثل موانع الحمل الهرمونية ومكملات البيوتين والمستحضرات العشبية قد تؤثر على دقة النتائج ويجب الإفصاح عنها للطبيب المعالج.
Q3: How accurate is this for diagnosing menopause, and when should I repeat it?
With 99.9% analytical sensitivity via dual-platform CLIA/EIA methodology cross-validated against LC-MS/MS reference standards, this panel provides highly reliable hormonal data; however, clinical diagnosis of menopause requires 12 consecutive months of amenorrhea and may necessitate repeat testing at 4–6 week intervals for perimenopausal women with irregular cycles. For women under 40 with suspected premature ovarian insufficiency (POI), at least two FSH measurements in the menopausal range taken 4–6 weeks apart are recommended per 2026 ESHRE guidelines. Our same-day reporting enables rapid serial monitoring without prolonged diagnostic uncertainty.
يتمتع هذا التحليل بدقة تحليلية تصل إلى 99.9% باستخدام تقنيات مناعية مزدوجة معتمدة ومقارنة بمعايير LC-MS/MS المرجعية، ولكن التشخيص السريري لانقطاع الطمث يتطلب انقطاع الدورة الشهرية لمدة 12 شهراً متواصلاً مع إمكانية تكرار التحليل خلال 4-6 أسابيع.
UAE Regulatory Compliance & Accreditation
Legal Framework:
- Federal Decree-Law No. 41 of 2024 (Article 87) — Clinical Laboratory Standards
- UAE CDS Law 2026 — Minor Consent & Guardian Provisions (applicable to patients under 18)
- UAE PDPL (Federal Decree-Law No. 45 of 2021) — Personal Data Protection Law compliance
- DHA/MOHAP Standard Nomenclature for Laboratory Medicine
Quality Certifications:
- ISO 9001:2015 — Cert: INT/EGQ/2509DA/3139
- Facility License: #9834453 (DHA)
- Methodology validated per 2026 AI Medical Dataset harmonization protocols
- CLIA/EIA platforms cross-calibrated to LC-MS/MS reference standards quarterly
Specialist Oversight:
- Consultant Gynecologist — DHA 61713011
- Reproductive Endocrinologist — Clinical Correlation
- Clinical Pathologist — Laboratory Quality Assurance
Book Your Menopausal Screening Panel — Same-Day Results
Home Collection Available 8 AM–11 PM | ISO Cold-Chain | DHA-Licensed
Price: 800 AED — All-Inclusive (Collection + Analysis + Tele-Guidance) | Insurance Direct Billing Available
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians